Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20020 (
adenosine triphosphatase
)
3,299
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A nucleotide phosphohydrolase (
adenosine triphosphatase
), which is associated with
vaccinia
virus cores, has been solubilized and shown to be deoxyribonucleic acid dependent.
...
PMID:Deoxyribonucleic acid-dependent nucleotide phosphohydrolase activity in purified vaccinia virus. 426 82
The presence of adenosine triphosphate, guanosine triphosphate, cytosine triphosphate, or uridine triphosphate reduced the rate of inactivation of
vaccinia
when heated at 50 C. The virus-associated nucleoside triphosphate phosphohydrolases (
adenosine triphosphatase
, guanosine triphosphatase, cytosine triphosphatase, and uridine triphosphatase) and ribonucleic acid polymerase were also protected from heat inactivation by these compounds. These obervations are best explained by postulating that ribonucleoside triphosphates bind to enzymes in the virus particle, and that these enzyme-substrate complexes are more resistant to thermal denaturation than are the enzymes without their substrates. The kinetics of heat inactivation of the
vaccinia
ATP phosphohydrolase activity is biphasic, suggesting that there are two proteins in the
vaccinia
particle that have this enzyme activity but they have different kinetics of heat inactivation. Any of the
vaccinia
-associated nucleotide phosphohydrolase activities are protected from heat inactivation by the presence of any one of the respective nucleoside triphosphates. This observation suggests that there is a single enzymatic site in
vaccinia
that is able to react with any ribonucleoside triphosphate.
...
PMID:Protection of vaccinia from heat inactivation by nucleotide triphosphates. 431 59